about
Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancerRole of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate CancermiRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue.miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancerPD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosisPercutaneous nephrolithotomy in patients with solitary kidney: a critical outcome analysis.Prima-1 induces apoptosis in bladder cancer cell lines by activating p53.MMP9 overexpression is associated with good surgical outcome in children with UPJO: Preliminary resultsThe challenge of cystine and struvite stone formers: clinical, metabolic and surgical assessment.The Effectiveness of a Systematic Algorithm for the Management of Vascular Injuries during the Laparoscopic Surgery.Tumor banks: the cornerstone of basic research in urology.Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer.The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior.Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer.The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability.MicroRNAs 143 and 145 may be involved in benign prostatic hyperplasia pathogenesis through regulation of target genes and proteins.MicroRNA 100: a context dependent miRNA in prostate cancer.Can we predict which patients will experience resolution of detrusor overactivity after transurethral resection of the prostate?Surgical performance during laparoscopic radical nephrectomy is improved with training in a porcine model.MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer.Prostate biopsy in patients with long-term use of indwelling bladder catheter: what is the rationale?Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer.Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy.Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy.Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics.The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults.The Obstructed Bladder: Expression of Collagen, Matrix Metalloproteinases, Muscarinic Receptors, and Angiogenic and Neurotrophic Factors in Patients With Benign Prostatic Hyperplasia.miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression.Assessment of a new kind of surgical simulator. The physical surgical simulator.Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.Correlation between chromosome 9p21 locus deletion and prognosis in clinically localized prostate cancer.MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer.Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.GREB1 tissue expression is associated with organ-confined prostate cancer.PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.Gene expression profile of renal cell carcinomas after neoadjuvant treatment with sunitinib: new pathways revealed.
P50
Q28545072-5278D9F7-9F0E-4A31-9AD9-8527EEC011BFQ28554766-C22EB6D5-5747-43FD-9FD3-465462B78631Q33500521-07C91B89-01A9-4025-B795-B8E3317B041AQ34285397-34952722-AA9D-462D-A33B-6FCD00DF437CQ35809165-35F7B19A-1FDD-4A80-8E9E-FA72C6F56477Q36575946-09618B11-1173-4238-BEE8-3786A1E4F8B2Q36727232-9B17F135-CD98-46C5-BBAC-92A48C2C2CEAQ37120338-80AC6C07-6865-4696-B93B-CDBEF576351EQ37344356-5A7FE009-C7EB-410A-A7F1-9FA38B6E3685Q37415109-90405360-0E89-472D-A88D-79E9D2D55F48Q37770133-605FD805-7A8F-4AF4-B2A3-05AA86C403F8Q38532073-062F1EF3-DE43-4E0D-A8EA-C0DF6FEE4DC1Q38881373-DE364012-4022-4D2D-8A0A-35BF9D4A3C1FQ38911575-835AA830-DAB5-4F7B-9118-2F538D82032FQ38930235-184F922F-5DF5-494A-B8A9-DB98F346AF2AQ39029450-CF20FD90-341A-430B-944C-FA8FCA71E0EAQ39137852-5E6FCF13-76EF-4D0E-A769-4B2DE5127297Q39195817-A4E1B079-2DAE-45C5-AA99-69312BF925C7Q39672904-274A5745-BF42-4875-B6D3-C837DEAF76B2Q39791122-30945A7F-DBE8-4D57-94BF-145F73A28291Q39954147-35F970A2-DD90-4F7C-B57F-38EC8E31FDC3Q40138683-346FCC95-0E0F-477D-BBAA-90CFD9159BA3Q41761066-736E4151-DD39-475F-A35A-2735CFC12919Q43760197-51DDA013-399F-4F87-B470-BF721899A9B9Q45906658-3964D87B-7461-4E48-8277-DBDD85856F48Q46418596-610F8E4B-5D63-4BAA-9D2F-3D76CE518E22Q47163897-669DF2CB-0CD9-41E5-9B45-C1D7F722E5FCQ48334562-3E3ECB0A-BE9C-4ADC-A8FA-F227C9EFCD29Q48649758-48FF1765-EA5F-4A37-A67C-D9FF29D158DCQ50024088-B67D6EBF-CC0C-4FF7-9D96-D422AB5435DCQ50056760-4C89AFBA-9923-43D0-8C7E-41E137203F73Q50710190-7B28C736-A58E-4526-9933-2F45E689A2C3Q50969422-DA83A926-8B08-4D90-87B2-BC9CA054DEE3Q53278027-2A4364DB-F6BC-4D06-8B4D-8AB11CEB6805Q53311174-67575F4A-0685-4438-A98D-6A725EF93396Q54291033-B160B704-FF71-4FE4-BB18-B8CF1638E543Q54311845-617C14EC-02BB-404F-BB2F-504D0748E659Q54452687-2EDD29E4-AEB1-4251-9595-1444B33FCA04Q54549406-53866B33-9861-4020-BB26-39D20E379B06Q55008199-943AAC9C-0E99-484E-9967-54641E098FC5
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-3564-3597
@en
name
Sabrina Thalita Reis
@ast
Sabrina Thalita Reis
@en
Sabrina Thalita Reis
@es
Sabrina Thalita Reis
@nl
type
label
Sabrina Thalita Reis
@ast
Sabrina Thalita Reis
@en
Sabrina Thalita Reis
@es
Sabrina Thalita Reis
@nl
altLabel
Sabrina Reis
@en
prefLabel
Sabrina Thalita Reis
@ast
Sabrina Thalita Reis
@en
Sabrina Thalita Reis
@es
Sabrina Thalita Reis
@nl
P106
P1153
26432175700
P21
P31
P496
0000-0002-3564-3597